Skip to content
Home/Companies/HealthTech/Exactcure

Exactcure

HealthTech·France·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns Exactcure?

Exactcure is a French HealthTech company, now owned by Quantum Genomics, which acquired it in 2024 from OneRagtime.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
OneRagtime
Investor
OneRagtime
OneRagtime Rhapsody II · 2021 · VC

Key facts

HQFrance
SectorHealthTech
Exit Type
Trade Sale
Buyer
Quantum Genomics
Exit Year
2024

More from OneRagtime Rhapsody II

Other portfolio companies in the same fund.

Monde Singulier
Monde Singulier
Active
ConsumerFrance· 2024
Rippletide
Rippletide
Active
SoftwareFrance· 2024
Stokelp
Stokelp
Active
IndustrialsFrance· 2023
Buster.Ai
Active
SoftwareFrance· 2022
Hive
Active
SoftwareFrance· 2022
Staycation
Staycation
Active
HospitalityFrance· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Exactcure?

Exactcure is now owned by Quantum Genomics, which acquired it in 2024 from OneRagtime.

When did Quantum Genomics acquire Exactcure?

Quantum Genomics acquired Exactcure in 2024, buying from OneRagtime.

Who did Exactcure sell to?

OneRagtime sold Exactcure to Quantum Genomics in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue